Related Experiment Video

Updated: Jun 3, 2025

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

2.1K

The Rise and Fall of C-Reactive Protein: Can it Predict Immune Checkpoint Inhibitor-Associated Venous

Tzu-Fei Wang1

  • 1Department of Medicine, University of Ottawa at The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

JACC. Cardiooncology
|January 13, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
C-reactive proteincancer-associated thrombosisimmune checkpoint inhibitorneoplasiarisk predictionvenous thromboembolism

More Related Videos

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis
04:34

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Published on: June 15, 2011

18.2K
Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins
05:44

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins

Published on: May 24, 2024

565

Related Experiment Videos

Last Updated: Jun 3, 2025

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

2.1K
Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis
04:34

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Published on: June 15, 2011

18.2K
Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins
05:44

Author Spotlight: Utilizing Venoplasty Balloon Model in Rodents to Simulate Surgical Interventions for Deep Veins

Published on: May 24, 2024

565

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

56
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
56

Articles linked to this work by shared authors, journal, and citation graph.

Performance status and outcomes in patients with cancer receiving thromboprophylaxis: a subanalysis of the AVERT trial.

Cardio-oncology (London, England)·2026

Primary Thromboprophylaxis in Patients with Malignancy and Central Venous Catheters: TRIM-Line Randomized Controlled Trial-Design and Rationale.

Thrombosis and haemostasis·2026

Diagnosis and management of subsegmental pulmonary embolism.

Journal of thrombosis and haemostasis : JTH·2026

Incidence and Risk of Venous Thromboembolism in Critical Care: A Population-based Observational Cohort Study.

Annals of the American Thoracic Society·2026

Recurrent VTE in patients with thrombophilia after stopping anticoagulation: a systematic review and meta-analysis.

Blood advances·2026

The association between patient preferred language and end-of-life outcomes of home care patients who died from a cancer in Ontario, Canada - A retrospective cohort study.

PloS one·2026

High-Sensitivity Cardiac Troponin T and I Discordance in Patients Receiving Immune Checkpoint Inhibitors.

JACC. CardioOncology·2026

Fibrotic Rewiring of CD8+ T Cells by Doxorubicin Drives Pathological Remodeling of Cardiac Extracellular Matrix.

JACC. CardioOncology·2026

Management and Surveillance of Immune Checkpoint Inhibitor Myocarditis: Managing the Aftermath: JACC CardioOncology State-of-the-Art Review.

JACC. CardioOncology·2026

Immune Responses in Checkpoint Inhibitor-Associated Cardiovascular Immune-Related Adverse Events: JACC: CardioOncology State-of-the-Art Review.

JACC. CardioOncology·2026

Association of Life's Essential 8 With Clonal Hematopoiesis and Coronary Artery Disease.

JACC. CardioOncology·2026

Real-World Cardiotoxicity of Biosimilar versus Reference Trastuzumab in Early HER2-Positive Breast Cancer.

JACC. CardioOncology·2026

Heart Rate Surge Improves Cardiovascular Risk Stratification Beyond Hypoxic Burden in Sleep Apnea.

JACC. Asia·2026

Intractable Pulmonary Edema After PCI: An Extremely Rare Iatrogenic Mechanical Cause.

JACC. Case reports·2026

Pacing Rate Acceleration in Right-Sided Heart Failure: Insight From an On-Off-On Clinical Course.

JACC. Case reports·2026

Assessment and Reversibility of Hepatic Abnormalities in Heart Failure: Liver in Heart Failure.

JACC. Heart failure·2026

Dynamic perioperative thrombo-inflammatory biomarkers correlate with early functional outcomes after mechanical thrombectomy for acute ischemic stroke.

Frontiers in neuroscience·2026

Postoperative platelet dynamic trajectories in patients with type A aortic dissection and development of a predictive model for thrombocytopenia.

Frontiers in cardiovascular medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us